<DOC>
	<DOCNO>NCT00773162</DOCNO>
	<brief_summary>To add understanding relationship blushing , symptom severity potential mechanism underlie blush patient Social Phobia ( SP ) , investigator propose compare SP patient ' vascular response topical m-N pre post treatment Seroquel placebo . Atypical antipsychotic seroquel use successfully adjunctive treatment anxiety disorder , include PTSD ( Labatte , 2001 ; Krashin &amp; Oates , 1999 ; McDougle et al. , 2000 ; Pfanner et al. , 2000 ; Bogetto et al. , 2000 ) Generalized Anxiety Disorder ( Katzman et al. , 2005 ) . Responses blush exposure assess prior follow treatment seroquel placebo one month follow intervention . Levels prostaglandin compare group also correlate symptom severity clinical group . The objective randomized , double blind flexible -dose study evaluate efficacy , safety tolerability seroquel SR 50mg 800mg placebo outpatient subject diagnose SP . The study begin single week Seroquel 50mg placebo . Subsequently , tablet administer investigator flexible dose fashion visit . Patients follow weekly ( biweekly week 6 ) clinician 's discretion . After fist week patient ' dosage increase maximum 800 mg daily expect average dose 300mg dail . This dose remain fixed 8 week treatment week 16 .</brief_summary>
	<brief_title>Flushing Social Anxiety Disorder Seroquel</brief_title>
	<detailed_description />
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>The patient provide sign informed consent prior studyrelated procedure Outpatient male female age 1865 ( inclusive ) . Patients primary diagnosis Social Phobia DSM IV ( 300.23 ) criterion ( diagnosis make use MINI International Neuropsychiatric Interview ( MINI ) . Score &gt; 60 LSAS . On basis physical examination , medical history basic laboratory screening , patient , investigator 's opinion , suitable condition . Pregnancy lactation Any DSMIV Axis I disorder define inclusion criterion Patients , opinion investigator , pose immediate risk suicide danger self others Known intolerance lack response quetiapine fumarate , judge investigator Use follow P450 3A4 inhibitor 14 day precede enrollment include limited : ketoconazole , itraconazole , fluconazole , erythromycin , clarithromycin , troleandomycin , indinavir , nelfinavir , ritonavir , fluvoxamine , saquinavir . Use follow cytochrome P450 inducer 14 day precede enrolment include limited : phenytoin , carbamazepine , barbiturate , rifampin , St. John 's Wort , glucocorticoid . Administration depot antipsychotic injection within one dose interval ( depot ) randomization Substance alcohol dependence enrolment ( except dependence full remission , except caffeine nicotine dependence ) , define DSMIV criterion Opiates , amphetamine , barbiturate , cocaine , cannabis , hallucinogen abuse DSMIV criterion within 4 week prior enrolment Positive drug screen result screen visit clinically relevant judge investigator Medical condition would affect absorption , distribution , metabolism , excretion study treatment Unstable inadequately treat medical illness ( e.g . diabetes , angina pectoris , hypertension ) judge investigator Involvement planning conduct study Previous enrollment randomization treatment present study Participation another drug trail within 4 week prior enrollment study long accordance local requirement Continuation commencement formal psychotherapy Current use commencement antidepressant anxiolytic medication Patients , antidepressant anxiolytic prior study , discontinue two week prior entry study . Those fluoxetine , least five week . Patients , herbal alternative treatment judge potentially anxiolytic psychobiological activity , terminate usage agent two week prior enter study Previous reaction Niacin administration Use nonsteroidal antiinflammatory Any psychotic disorder Eating disorder define DSM IV Mental retardation cognitive disorder Laboratory value screen medical history may consider clinical interpretation significant Serious illness : Liver renal insufficiency , cardiac , vascular , pulmonary , gastrointestinal , endocrine , neurological , infectious , neoplastic metabolic disturbance An absolute neutrophil count ( ANC ) &lt; 1.5 x 109 per liter . Unstable Diabetes Mellitus/HbA1c</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>